Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $429.87 USD
Change Today +0.94 / 0.22%
Volume 1.9M
As of 8:10 PM 03/27/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Spyros Artavanis-Tsakonas Ph.D.

Chief Scientific Officer and Senior Vice President, Biogen Idec Inc.
AgeTotal Calculated CompensationThis person is connected to 11 board members in 2 different organizations across 4 different industries.

See Board Relationships
67--

Background*

Prof. Spyros Artavanis-Tsakonas, Ph.D. has been the Chief Scientific Officer and Senior Vice President of Biogen Idec Inc. since May 2013. Prof. Artavanis-Tsakonas is the Scientific Co-Founder of Exelixis Pharmaceuticals, Inc., Cellzome and Anadys Pharmaceuticals, Inc. He serves as the President of Fondation Santé. Prof. Artavanis-Tsakonas served as Interim Chief Scientific Officer while on sabbatical from Harvard Medical School. He serves as the Chairman of Novartis ...

Read Full Background

Corporate Headquarters*

225 Binney Street
Cambridge, Massachusetts 02142

United States

Phone: 617-679-2000
Fax: --

Board Members Memberships*

President and Director
Chairman

Education*

PhD
University of Cambridge
MS
Eidgenössische Technische Hochschule Zürich
Post-Doctoral Training
Stanford University
Post-Doctoral Training
Universität Basel

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BIIB:US $429.87 USD +0.94

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Lamberto Andreotti Chief Executive Officer, Director, Member of Executive Committee and Member of Securities Issuance Committee
Bristol-Myers Squibb Company
$1.7M
Robert J. Hugin MBAChairman, Chief Executive Officer and Chairman of Executive Committee
Celgene Corporation
$1.3M
John C. Lechleiter Ph.D.Chairman, Chief Executive Officer and President
Eli Lilly and Company
$1.5M
Lars Rebien Sørensen Chief Executive Officer and Member of Executive Management
Novo Nordisk A/S
kr15.2M
Yoshihiko Hatanaka Chief Executive Officer, President and Representative Director
Astellas Pharma, Inc.
¥170.0M
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BIOGEN IDEC INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.